Literature DB >> 36201019

Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.

Zhichao Wu1, Sharika Rajan1, Hye-Jung Chung1, Mark Raffeld1, Pavalan Panneer Selvam1, Leonille Schweizer2, Arie Perry3, David Samuel4, Caterina Giannini5, Aditya Ragunathan5, Matthew P Frosch6, Michael S Marshall6, Daniel R Boué7, Kliment Donev8, Stewart G Neill9, Igor Fernandes10, Adam Resnick11, Brian Rood12, Thomas J Cummings13, Anne F Buckley13, Linda Szymanski14, Osorio Lopes Abath Neto15, Leor Zach16, Howard Colman17, Samuel Cheshier18, Jennifer Ziskin19, Manoj Tyagi1, David Capper2,20, Zied Abdullaev1, Patrick J Cimino21, Martha Quezado1, Drew Pratt1, Kenneth Aldape22.   

Abstract

Entities:  

Year:  2022        PMID: 36201019     DOI: 10.1007/s00401-022-02508-2

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   15.887


× No keyword cloud information.
  9 in total

1.  New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

Authors:  Dominik Sturm; Brent A Orr; Umut H Toprak; Volker Hovestadt; David T W Jones; David Capper; Martin Sill; Ivo Buchhalter; Paul A Northcott; Irina Leis; Marina Ryzhova; Christian Koelsche; Elke Pfaff; Sariah J Allen; Gnanaprakash Balasubramanian; Barbara C Worst; Kristian W Pajtler; Sebastian Brabetz; Pascal D Johann; Felix Sahm; Jüri Reimand; Alan Mackay; Diana M Carvalho; Marc Remke; Joanna J Phillips; Arie Perry; Cynthia Cowdrey; Rachid Drissi; Maryam Fouladi; Felice Giangaspero; Maria Łastowska; Wiesława Grajkowska; Wolfram Scheurlen; Torsten Pietsch; Christian Hagel; Johannes Gojo; Daniela Lötsch; Walter Berger; Irene Slavc; Christine Haberler; Anne Jouvet; Stefan Holm; Silvia Hofer; Marco Prinz; Catherine Keohane; Iris Fried; Christian Mawrin; David Scheie; Bret C Mobley; Matthew J Schniederjan; Mariarita Santi; Anna M Buccoliero; Sonika Dahiya; Christof M Kramm; André O von Bueren; Katja von Hoff; Stefan Rutkowski; Christel Herold-Mende; Michael C Frühwald; Till Milde; Martin Hasselblatt; Pieter Wesseling; Jochen Rößler; Ulrich Schüller; Martin Ebinger; Jens Schittenhelm; Stephan Frank; Rainer Grobholz; Istvan Vajtai; Volkmar Hans; Reinhard Schneppenheim; Karel Zitterbart; V Peter Collins; Eleonora Aronica; Pascale Varlet; Stephanie Puget; Christelle Dufour; Jacques Grill; Dominique Figarella-Branger; Marietta Wolter; Martin U Schuhmann; Tarek Shalaby; Michael Grotzer; Timothy van Meter; Camelia-Maria Monoranu; Jörg Felsberg; Guido Reifenberger; Matija Snuderl; Lynn Ann Forrester; Jan Koster; Rogier Versteeg; Richard Volckmann; Peter van Sluis; Stephan Wolf; Tom Mikkelsen; Amar Gajjar; Kenneth Aldape; Andrew S Moore; Michael D Taylor; Chris Jones; Nada Jabado; Matthias A Karajannis; Roland Eils; Matthias Schlesner; Peter Lichter; Andreas von Deimling; Stefan M Pfister; David W Ellison; Andrey Korshunov; Marcel Kool
Journal:  Cell       Date:  2016-02-25       Impact factor: 41.582

2.  Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.

Authors:  Matthew Torre; David M Meredith; Adrian Dubuc; David A Solomon; Arie Perry; Varshini Vasudevaraja; Jonathan Serrano; Matija Snuderl; Keith L Ligon; Sanda Alexandrescu
Journal:  J Neuropathol Exp Neurol       Date:  2019-04-01       Impact factor: 3.685

3.  Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report.

Authors:  Ayako Yamazaki; Yasuhito Arai; Kohei Fukuoka; Yoshiko Nakano; Natsuko Hama; Satoshi Nakata; Keishi Makino; Jun-Ichiro Kuroda; Naoki Shinojima; Akitake Mukasa; Yoshiki Mikami; Koichi Ichimura; Tatsuhiro Shibata; Hideaki Yokoo; Sumihito Nobusawa
Journal:  Brain Tumor Pathol       Date:  2022-05-21       Impact factor: 3.298

4.  Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.

Authors:  Cristina R Antonescu; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Hsiao-Wei Chen; Samuel Singer; Narasimhan P Agaram; Andrea Sboner; Christopher D Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2013-11-28       Impact factor: 5.006

Review 5.  Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.

Authors:  Lazaro De Lima; Mehmet Beşir Sürme; Marco Gessi; Angela Mastronuzzi; Evelina Miele; Gianpiero Tamburrini; Luca Massimi
Journal:  Childs Nerv Syst       Date:  2020-06-15       Impact factor: 1.475

6.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.

Authors:  Craig H Mermel; Steven E Schumacher; Barbara Hill; Matthew L Meyerson; Rameen Beroukhim; Gad Getz
Journal:  Genome Biol       Date:  2011-04-28       Impact factor: 13.583

7.  Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.

Authors:  David J Pisapia; Kentaro Ohara; Rohan Bareja; David C Wilkes; Erika Hissong; Jaclyn A Croyle; Joon-Hyung Kim; Jad Saab; Theresa Y MacDonald; Shaham Beg; Catherine O'Reilly; Sarah Kudman; Mark A Rubin; Olivier Elemento; Andrea Sboner; Jeffrey Greenfield; Juan Miguel Mosquera
Journal:  Acta Neuropathol Commun       Date:  2020-06-03       Impact factor: 7.801

Review 8.  BCOR involvement in cancer.

Authors:  Annalisa Astolfi; Michele Fiore; Fraia Melchionda; Valentina Indio; Salvatore N Bertuccio; Andrea Pession
Journal:  Epigenomics       Date:  2019-05-31       Impact factor: 4.778

9.  The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".

Authors:  Arnault Tauziède-Espariat; Gaëlle Pierron; Aurore Siegfried; Delphine Guillemot; Emmanuelle Uro-Coste; Yvan Nicaise; David Castel; Isabelle Catalaa; Delphine Larrieu-Ciron; Patrick Chaynes; Amaury de Barros; Julien Nicolau; Albane Gareton; Emmanuèle Lechapt; Fabrice Chrétien; Franck Bourdeaut; François Doz; Yassine Bouchoucha; Jacques Grill; Kévin Beccaria; Nathalie Boddaert; Raphaël Saffroy; Mélanie Pagès; Pascale Varlet
Journal:  Acta Neuropathol Commun       Date:  2020-11-02       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.